A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity

P.M. Ambühl; A.C. Tissot; Alma Fulurija; P. Maurer; J. Nussberger; R. Sabat; V. Nief; C. Schellekens; K. Sladko; K. Roubicek; T. Pfister; M. Rettenbacher; H.-D. Volk; F. Wagner; P. Müller; G.T. Jennings; M.F. Bachmann

doi:10.1097/HJH.0b013e32800ff5d6

A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity

P.M. Ambühl, A.C. Tissot, Alma Fulurija, P. Maurer, J. Nussberger, R. Sabat, V. Nief, C. Schellekens, K. Sladko, K. Roubicek, T. Pfister, M. Rettenbacher, H.-D. Volk, F. Wagner, P. Müller, G.T. Jennings, M.F. Bachmann

Marshall Centre

Research output: Contribution to journal › Article › peer-review

212 Citations (Scopus)

Original language	English
Pages (from-to)	63-72
Journal	Journal of Hypertension
Volume	25
Issue number	1
DOIs	https://doi.org/10.1097/HJH.0b013e32800ff5d6
Publication status	Published - 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/HJH.0b013e32800ff5d6

Cite this

Ambühl, P. M., Tissot, A. C., Fulurija, A., Maurer, P., Nussberger, J., Sabat, R., Nief, V., Schellekens, C., Sladko, K., Roubicek, K., Pfister, T., Rettenbacher, M., Volk, H.-D., Wagner, F., Müller, P., Jennings, G. T., & Bachmann, M. F. (2007). A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity. Journal of Hypertension, 25(1), 63-72. https://doi.org/10.1097/HJH.0b013e32800ff5d6

@article{0f5689047c704932bb9079f9a286d55a,

title = "A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity",

author = "P.M. Amb{\"u}hl and A.C. Tissot and Alma Fulurija and P. Maurer and J. Nussberger and R. Sabat and V. Nief and C. Schellekens and K. Sladko and K. Roubicek and T. Pfister and M. Rettenbacher and H.-D. Volk and F. Wagner and P. M{\"u}ller and G.T. Jennings and M.F. Bachmann",

year = "2007",

doi = "10.1097/HJH.0b013e32800ff5d6",

language = "English",

volume = "25",

pages = "63--72",

journal = "Journal of Hypertension",

issn = "0263-6352",

publisher = "Lippincott Williams & Wilkins",

number = "1",

}

Ambühl, PM, Tissot, AC, Fulurija, A, Maurer, P, Nussberger, J, Sabat, R, Nief, V, Schellekens, C, Sladko, K, Roubicek, K, Pfister, T, Rettenbacher, M, Volk, H-D, Wagner, F, Müller, P, Jennings, GT & Bachmann, MF 2007, 'A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity', Journal of Hypertension, vol. 25, no. 1, pp. 63-72. https://doi.org/10.1097/HJH.0b013e32800ff5d6

TY - JOUR

T1 - A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity

AU - Ambühl, P.M.

AU - Tissot, A.C.

AU - Fulurija, Alma

AU - Maurer, P.

AU - Nussberger, J.

AU - Sabat, R.

AU - Nief, V.

AU - Schellekens, C.

AU - Sladko, K.

AU - Roubicek, K.

AU - Pfister, T.

AU - Rettenbacher, M.

AU - Volk, H.-D.

AU - Wagner, F.

AU - Müller, P.

AU - Jennings, G.T.

AU - Bachmann, M.F.

PY - 2007

Y1 - 2007

U2 - 10.1097/HJH.0b013e32800ff5d6

DO - 10.1097/HJH.0b013e32800ff5d6

M3 - Article

C2 - 17143175

SN - 0263-6352

VL - 25

SP - 63

EP - 72

JO - Journal of Hypertension

JF - Journal of Hypertension

IS - 1

ER -